| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 25, 2025 | ALUMIS INC. | Director | Buy | 90.0 | +72,212 | 2.84% | ✗ | $532.9K |
| Nov 17, 2025 | Nov 19, 2025 | ALUMIS INC. | Director | Buy | 100.0 | +507,874 | 24.97% | ✗ | $3.1M |
| May 2, 2025 | May 6, 2025 | ALUMIS INC. | Director | Buy | 82.5 | +45,000 | 1.07% | ✗ | $202.3K |
| Jul 1, 2024 | Jul 3, 2024 | ALUMIS INC. | Director | Buy | 100.0 | +2,500,000 | 34.31% | ✗ | $40M |
| Aug 14, 2020 | Oct 19, 2020 | Disc Medicine, Inc. | CEO | Buy | 100.0 | +441,500 | 100.00% | ✗ | $4.4M |
| May 12, 2020 | May 14, 2020 | 10x Genomics, Inc. | 10% Owner | Sell | 15.0 | -1,450,000 | -19.86% | ✗ | $116.2M |
| Mar 4, 2020 | Mar 19, 2020 | 10x Genomics, Inc. | 10% Owner | Sell | 15.0 | -1,571,803 | -45.52% | ✗ | $44.3M |
| Sep 12, 2019 | Sep 16, 2019 | 10x Genomics, Inc. | 10% Owner | Buy | 100.0 | +187,500 | 100.00% | ✗ | $7.3M |